Viracta Therapeutics (NASDAQ:VIRX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Viracta Therapeutics (VIRX) operate in?

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viracta Therapeutics Stock (NASDAQ: VIRX) stock price, news, charts, stock research, profile.

Open	$0.15
Close	$0.16
Volume / Avg.	549.64K / 1.04M
Day Range	$0.15 - $0.17
52 Wk Range	0.13 - 1.31
Market Cap	$6.12M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	8.59%
Days to Cover	1

Recent News

Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday?

Viracta Therapeutics stock gains after Phase 2 NAVAL-1 trial results for relapsed or refractory EBV+ PTCL cohort. The company plans pipeline reprioritization and a reduction in force.

Vandana Singh

Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.15
Close	$0.16
Volume / Avg.	549.64K / 1.04M
Day Range	$0.15 - $0.17
52 Wk Range	0.13 - 1.31
Market Cap	$6.12M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	8.59%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viracta Therapeutics (VIRX) stock?

You can purchase shares of Viracta Therapeutics (NASDAQ:VIRX) through any online brokerage.

View our list of the best stock brokerages

Who are Viracta Therapeutics (VIRX) competitors?

Other companies in Viracta Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN), Evaxion Biotech (NASDAQ:EVAX) and ABVC BioPharma (NASDAQ:ABVC).

What is the forecast, or price target, for Viracta Therapeutics (VIRX) stock?

Viracta Therapeutics has a consensus price target of $5.83.

What is the current price for Viracta Therapeutics (VIRX)?

The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $0.154 last updated November 22, 2024 at 6:37 PM EST.

Does Viracta Therapeutics (VIRX) pay a dividend?

There are no upcoming dividends for Viracta Therapeutics.

When is Viracta Therapeutics (NASDAQ:VIRX) reporting earnings?

Viracta Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Viracta Therapeutics (VIRX) going to split?

There is no upcoming split for Viracta Therapeutics.

What sector and industry does Viracta Therapeutics (VIRX) operate in?

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Viracta Therapeutics

Viracta Therapeutics (VIRX) Forecast